SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 782.47 |
| Enterprise Value ($M) | 711.30 |
| Book Value ($M) | 400.88 |
| Book Value / Share | 8.71 |
| Price / Book | 1.95 |
| NCAV ($M) | 359.94 |
| NCAV / Share | 7.82 |
| Price / NCAV | 2.17 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.36 |
| Return on Assets (ROA) | -1.87 |
| Return on Equity (ROE) | -3.78 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 18.95 |
| Current Ratio | 18.95 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 410.02 |
| Assets | 450.96 |
| Liabilities | 50.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Janus Henderson Group Plc | 5.80 | -1.02 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 5.90 | 20.36 | |
| 13G/A | Samsara BioCapital, L.P. | 9.60 | 7.13 | |
| 13G/A | Rtw Investments, Lp | 9.99 | ||
| 13G | BlackRock, Inc. | 5.50 | 0.00 | |
| 13G/A | Red Tree GP, LLC | 4.60 | -15.02 | |
| 13G | Third Rock Ventures V, L.P. | 4.40 | ||
| 13G/A | Perceptive Advisors Llc | 8.30 | 5.87 | |
| 13G/A | Fmr Llc | 15.00 | 6.55 | |
| 13G | Nextech VII GP S.a r.l. | 6.80 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 257,752 | 460,637 | 55.96 | |
| 33,193 | 207,565 | 15.99 | |
| 37,792 | 166,248 | 22.73 | |
| 27,488 | 122,747 | 22.39 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| COLL – Collegium Pharmaceutical, Inc. | CPIX – Cumberland Pharmaceuticals Inc. |
| CRBU – Caribou Biosciences, Inc. | CRNX – Crinetics Pharmaceuticals, Inc. |
| CTMX – CytomX Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io